New drug DS3790a enters human trials for blood cancers
NCT ID NCT07220616
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study tests a new drug called DS3790a in people with blood cancers. The goal is to check its safety and how well it works, alone or with other treatments. About 420 adults will take part. The study is currently recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGICAL MALIGNANCIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGNew York, New York, 10065, United States
Contact
-
Research Site
RECRUITINGLille, 59037, France
Contact
-
Research Site
RECRUITINGNagoya, 464-8681, Japan
Contact
-
Research Site
RECRUITINGTokyo, 104-0045, Japan
Contact
-
Research Site
RECRUITINGTokyo, 135-8550, Japan
Contact
Conditions
Explore the condition pages connected to this study.